Atlas Trials

Hansa Biopharma AB

16 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hansa Biopharma AB

RecordFirmDate
A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group (NCT05937750)Hansa Biopharma AB2023-07-03
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (NCT05753930)Hansa Biopharma AB2023-06-02
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (NCT05714514)Hansa Biopharma AB2023-04-21
A Study With Imlifidase in Anti-GBM Disease (NCT05679401)Hansa Biopharma AB2022-12-22
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation (NCT05049850)Hansa Biopharma AB2022-12-16
Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (NCT05369975)Hansa Biopharma AB2022-04-19
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (NCT04935177)Hansa Biopharma AB2021-10-14
An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR (NCT04711850)Hansa Biopharma AB2021-01-20
An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients (NCT03897205)Hansa Biopharma AB2019-04-30
A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation (NCT03611621)Hansa Biopharma AB2018-06-27

Track Hansa Biopharma AB automatically

Every clearance here is in the API, with alerts when new ones post.